Charles River Laboratories International (MIL:1CRL) Tariff Resilience Score: 6/10 (As of Jul. 07, 2026)


MIL:1CRL Charles River Laboratories International Inc MIL:1CRL
70 GF Score
Price €143.90
GF Value €120.87
! 8 Warning Signs
View Full Analysis

What is Charles River Laboratories International Tariff Resilience Score?

Charles River Laboratories International MIL:1CRL 70 Tariff Resilience Score is 6 as of Jul. 07, 2026. GuruFocus rates MIL:1CRL with a GF Score™ of 70/100 and a GF Value™ of €120.87. The stock has 8 warning signs investors should review. Among 216 Medical Diagnostics & Research companies, Charles River Laboratories International ranks better than 87.5% on this metric.

Charles River Laboratories International has the Tariff Resilience Score of 6, which implies that the company might have Average Resilient.

Charles River Laboratories International has CRL's global operations in the life sciences sector face moderate tariff risks. The company has diversified suppliers and can leverage its strong market position to offset potential impacts.

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Charles River Laboratories International might have Average Resilient.

Charles River Laboratories International  (MIL:1CRL) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Charles River Laboratories International Tariff Resilience Score Related Terms

MIL:1CRL vs RVTY, QGEN, ICLR: Tariff Resilience Score Comparison

For the Diagnostics & Research subindustry, Charles River Laboratories International's Tariff Resilience Score, along with its competitors' market caps and Tariff Resilience Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Charles River Laboratories International Tariff Resilience Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Charles River Laboratories International's Tariff Resilience Score distribution charts can be found below:

* The bar in red indicates where Charles River Laboratories International's Tariff Resilience Score falls into.


MIL:1CRL
70GF Score
Charles River Laboratories International Inc MIL:1CRL
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Tariff Resilience Score of 6 mean?
Charles River Laboratories International (MIL:1CRL) has a Tariff Resilience Score of 6 as of Jul. 07, 2026. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. According to the industry distribution chart, Charles River Laboratories International ranks #27 out of 216 companies in the Medical Diagnostics & Research industry, placing it in the top 12.5%.
Is Charles River Laboratories International's Tariff Resilience Score too high?
Charles River Laboratories International's current Tariff Resilience Score is 6. Based on the distribution chart, Charles River Laboratories International ranks #27 out of 216 companies in the Medical Diagnostics & Research industry, which is in the top quartile — a strong position relative to peers. Overall, Charles River Laboratories International has a GF Score™ of 70/100, reflecting its overall financial health beyond just this single metric.
How does Charles River Laboratories International's Tariff Resilience Score compare to RVTY and QGEN?
According to the Medical Diagnostics & Research industry distribution chart, Charles River Laboratories International ranks #27 out of 216 companies for Tariff Resilience Score. This places Charles River Laboratories International in the top 13% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tariff Resilience Score for a Medical Diagnostics & Research company?
A good Tariff Resilience Score depends on the Medical Diagnostics & Research industry context. However, Tariff Resilience Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tariff Resilience Score mean?
A high Tariff Resilience Score can signal that a stock is expensive relative to its fundamentals. Tariff Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more. Charles River Laboratories International's current Tariff Resilience Score is 6. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charles River Laboratories International stock overvalued right now?
Charles River Laboratories International (MIL:1CRL) has a current Tariff Resilience Score of 6. The stock's GF Value™ is €120.87, compared to a current price of €143.90 — trading 19.1% above its estimated fair value. The current Tariff Resilience Score is 6. Charles River Laboratories International's overall GF Score™ is 70/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tariff Resilience Score calculated?
Tariff Resilience Score is calculated from a company's financial statements. For Charles River Laboratories International (MIL:1CRL), the current Tariff Resilience Score is 6 as of Jul. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charles River Laboratories International (MIL:1CRL) Overvalued in 2026?

Based on GuruFocus' analysis, Charles River Laboratories International stock appears to be overvalued. The current stock price of €143.90 is trading 19.1% above its estimated GF Value™ of €120.87.

Key valuation signals for MIL:1CRL:

  • Tariff Resilience Score: 6
  • GF Value™: €120.87 vs. price of €143.90 (19.1% above fair value)
  • GF Score™: 70/100 with 8 warning signs

No single metric tells the full story. See the MIL:1CRL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charles River Laboratories International Business Description

Other Exchanges CRL:USARV6:Germany
Address 251 Ballardvale Street, Wilmington, MA, USA, 01887
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.
70GF Score

Get the complete analysis for MIL:1CRL

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€143.90
Price
€120.87
GF Value